Robles BioCeutics Appoints Chief Financial Officer
Dr. Joseph Ellis to Drive Next Phase of Growth for Stem Cell Senolytics Biotechnology Company
SAN DIEGO, March 4, 2025 /PRNewswire/ -- Robles BioCeutics, a regenerative dermatology biotechnology company focused on developing next-generation skin care solutions through stem cell and senolytic technologies, is pleased to announce the appointment of Dr. Joseph Ellis as its Chief Financial Officer (CFO).
"In less than a year, Maria Robles has achieved remarkable milestones, including scientific proof of concept for the company's first product1, filing multiple patents, establishing a 'share for work' collaborative agreement with an internationally renowned biotechnology organization2, and recruiting the recognized leader of stem cells and dermatology, Jorge Genevese, M.D., Ph.D., as the company's Chief Scientific Officer3," said Dr. Ellis. "I am honored to join Robles BioCeutics during this transformative phase of hyper-accelerated growth and to collaborate with Maria to drive the company's mission forward."
Dr. Ellis holds a Doctorate from Samuel Merritt University and is a Certified Financial Planner (CFP®), adhering to the highest standards of education, training, and ethics in the financial planning industry. Additionally, as an Enrolled Agent (EA), Dr. Ellis brings extensive expertise in tax matters and a comprehensive understanding of IRS protocols. His accomplishments include recognition as one of the top five financial advisors in the San Diego Union-Tribune Reader's Poll.
"I am thrilled to welcome Dr. Ellis to the Robles BioCeutics leadership team," said Maria Robles, CEO and President. "His unique combination of financial expertise and passion for advancing innovative companies is perfectly aligned with our mission to transform skin health through regenerative science. With a proven track record of running multi-million-dollar businesses, Dr. Ellis is well-positioned to guide us in financial strategy and operational efficiency as we continue to expand our clinical research and collaborative partnerships."
In addition to his financial credentials, Dr. Ellis is an accomplished author of two books and numerous articles featured in major publications. He is also an international lecturer, sharing his expertise on both medical and financial strategies with audiences worldwide.
About Robles BioCeutics Robles BioCeutics is a regenerative dermatology company dedicated to developing science-driven, effective solutions for skin health and beauty. Founded by Maria Robles, the company's mission is to harness the power of advanced biotechnology in stem cell and senolytics to create products that amplify the skin's natural regenerative processes.
For updates, follow Robles BioCeutics on Instagram, Twitter, Facebook, and Youtube, or visit us at https://roblesbioceutics.com.
For more information, please contact: Maria Robles
CEO and President
Robles BioCeutics
390914@email4pr.com
858-609-0948
View original content to download multimedia:https://www.prnewswire.com/news-releases/robles-bioceutics-appoints-chief-financial-officer-302391548.html
SOURCE Robles BioCeutics